Publicacións nas que colabora con Eduardo Carracedo Martínez (17)

2024

  1. Outpatient glucocorticoid use and COVID-19 outcomes: a population-based study

    Inflammopharmacology, Vol. 32, Núm. 4, pp. 2305-2315

  2. The role of traditional NSAIDs and selective COX-2 inhibitors on COVID-19 outcomes: a real-world data study

    Inflammopharmacology

2023

  1. Effect of Previous Anticoagulant Treatment on Risk of COVID-19

    Drug Safety, Vol. 46, Núm. 3, pp. 273-281

  2. Repurposing selective serotonin reuptake inhibitors for severity of COVID-19: A population-based study

    European Neuropsychopharmacology, Vol. 71, pp. 96-108

2022

  1. Impact on In- and Out-of-Hospital Drug Prescriptions of Including a More Expensive Me-Too Antidepressant in a Hospital Drug Formulary: a Controlled Longitudinal Study

    Pharmacoepidemiology and Drug Safety, Vol. 31, Núm. 5, pp. 556-565

2020

  1. Impact of a change of bronchodilator medications in a hospital drug formulary on intra- A nd out-of-hospital drug prescriptions: Interrupted time series design with comparison group

    Implementation Science, Vol. 15, Núm. 1

  2. Impact of a health alert and its implementation on flutamide prescriptions for women: an interrupted time series analysis

    BMC health services research, Vol. 20, Núm. 1, pp. 597

2019

  1. Computerized Clinical Decision Support Systems and Antibiotic Prescribing: A Systematic Review and Meta-analysis

    Clinical Therapeutics, Vol. 41, Núm. 3, pp. 552-581

  2. Impact of removal and restriction of me-too medicines in a hospital drug formulary on in- and outpatient drug prescriptions: interrupted time series design with comparison group

    Implementation science : IS, Vol. 14, Núm. 1, pp. 75

2018

  1. Impact of Health Authority Control Measures Aimed at Reducing the Illicit Use of Anabolic-Androgenic Steroids

    European Addiction Research, Vol. 24, Núm. 1, pp. 28-36

2017

  1. Trends in celecoxib and etoricoxib prescribing following removal of prior authorization requirement in Spain

    Journal of Clinical Pharmacy and Therapeutics, Vol. 42, Núm. 2, pp. 185-188

2012

  1. Impact of a health safety warning and prior authorisation on the use of piroxicam: A time-series study

    Pharmacoepidemiology and Drug Safety, Vol. 21, Núm. 3, pp. 281-284

2010

  1. Case-crossover analysis of air pollution health effects: A systematic review of methodology and application

    Environmental Health Perspectives, Vol. 118, Núm. 8, pp. 1173-1182

2009

  1. Fundamentos y aplicaciones del diseño de casos cruzados

    Gaceta Sanitaria, Vol. 23, Núm. 2, pp. 161-165

2008

  1. Effect of short-term exposure to air pollution and pollen on medical emergency calls: A case-crossover study in Spain

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 63, Núm. 3, pp. 347-353

2006

  1. Tratamiento estadístico de la falta de respuesta en estudios epidemiológicos transversales

    Salud Publica de Mexico, Vol. 48, Núm. 4, pp. 341-347

2005

  1. Analysis of case-crossover designs using longitudinal approaches: A simulation study

    Epidemiology, Vol. 16, Núm. 2, pp. 239-246